Anfal Saeed Bin Shamma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anfal Saeed Bin Shamma has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Bazigha Kadhim Abdul Rasool
Pharmaceutical Sciences Department, College of Pharmacy, Dubai Medical University, Dubai 20170, United Arab Emirates
1 shared publication - Fatima Abdallah
Pharmaceutics Department, Dubai Pharmacy College For Girls, Muhaisnah-1, Al Mizhar, Dubai P.O. Box 19099, United Arab Emirates
1 shared publication - Nema Al Mahri
Pharmaceutics Department, Dubai Pharmacy College For Girls, Muhaisnah-1, Al Mizhar, Dubai P.O. Box 19099, United Arab Emirates
1 shared publication - Nora Alburaimi
Pharmaceutics Department, Dubai Pharmacy College For Girls, Muhaisnah-1, Al Mizhar, Dubai P.O. Box 19099, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 29 June 2022
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 90 (3) , 39
A Narrative Review of the Potential Roles of Lipid-Based Vesicles (Vesiculosomes) in Burn Management
Burn injuries can have a lasting effect on people’s quality of life, as they negatively impact their physical and mental health. Then, they are likely to suffer psychological problems as a result. A serious problem is that deep burns are more challenging to treat due to their slow healing rate and susceptibility to microbial infection. Conventional topical medications used for burn treatment are sometimes ineffective because they cannot optimize their ability of transcutaneous absorption at the targeted site and accelerate healing. However, nanotechnology offers excellent prospects for developing current medical wound therapies and is capable of addressing issues such as low drug stability, water solubility, permeability, and bioavailability. The current review focuses on lipid-based vesicles (vesiculosomes) as an example of advanced delivery systems, showing their potential clinical applications in burn wound management. Vesiculosomes may help overcome impediments including the low bioavailability of active agents, offering the controlled release of drugs, increased drug stability, fewer side effects, and reduced dosing frequency, which will ultimately improve therapeutic efficacy and patient compliance. We discuss the application of various types of vesiculosomes such as liposomes, niosomes, ethosomes, cubosomes, transfersomes, and phytosomes in burn healing therapy, as these demonstrate superior skin penetration compared to conventional burn topical treatment. We also highlight their noteworthy uses in the formulation of natural products and discuss the current status as well as future perspectives of these carriers in burn management. Furthermore, the burn treatment options currently available in the market are also summarized.
- 29 June 2022
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 90 (3) , 39
Open AccessA Narrative Review of the Potential Roles of Lipid-Based Vesicles (Vesiculosomes) in Burn Management
Burn injuries can have a lasting effect on people’s quality of life, as they negatively impact their physical and mental health. Then, they are likely to suffer psychological problems as a result. A serious problem is that deep burns are more challenging to treat due to their slow healing rate and susceptibility to microbial infection. Conventional topical medications used for burn treatment are sometimes ineffective because they cannot optimize their ability of transcutaneous absorption at the targeted site and accelerate healing. However, nanotechnology offers excellent prospects for developing current medical wound therapies and is capable of addressing issues such as low drug stability, water solubility, permeability, and bioavailability. The current review focuses on lipid-based vesicles (vesiculosomes) as an example of advanced delivery systems, showing their potential clinical applications in burn wound management. Vesiculosomes may help overcome impediments including the low bioavailability of active agents, offering the controlled release of drugs, increased drug stability, fewer side effects, and reduced dosing frequency, which will ultimately improve therapeutic efficacy and patient compliance. We discuss the application of various types of vesiculosomes such as liposomes, niosomes, ethosomes, cubosomes, transfersomes, and phytosomes in burn healing therapy, as these demonstrate superior skin penetration compared to conventional burn topical treatment. We also highlight their noteworthy uses in the formulation of natural products and discuss the current status as well as future perspectives of these carriers in burn management. Furthermore, the burn treatment options currently available in the market are also summarized.